The Supreme Court dismissed the government’s review petition in the Vodafone tax case on Tuesday, affirming its January ruling that put overseas transfers of shares outside the Indian tax net. The review petition and last week’s budget proposals seeking retrospective changes have revived the uncertainty over tax laws, according to government officials, the Planning Commission and businesses. If Parliament passes the budget in its current form, the judgement in the Vodafone case...

The government introduced a retrospective clarification to the Income-Tax (I-T) Act, 1961, virtually amending the law to ensure that cross-border transactions such as the $11.08 billion (around Rs55,735 crore today) Vodafone-Hutchison deal are taxable. The Supreme Court had ruled this deal as not being taxable in India. The amendment becomes crucial because a review petition by the government on this case is pending before the Supreme Court, which might now have...

-The Telegraph The Economic Survey — prepared by Kaushik Basu, chief economic adviser to the finance ministry — has some gratuitous advice for politicians like Mamata Banerjee who announced earlier this week plans to amend state legislation that will require co-operative banks to take government permission before seizing mortgaged property while trying to foreclose loans given to defaulting farmers. “The state provides the laws and enforcement to enable people to sign contracts,”...

-PTI The government has pegged its outgo on food, fuel and fertiliser subsidies in the 2012-13 fiscal at over Rs1.79 lakh crore, nearly 14% lower than the revised estimates for the current fiscal. According to the Budget proposals, the government's subsidy bill on food, petroleum and fertilisers is estimated at Rs1,79,554 crore for the 2012-13 fiscal as against Rs2,08,503 crore in the revised estimates for this fiscal. Interestingly, the revised estimate for this...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...